A Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy
This study has been completed.
Sponsor:
Providence Health & Services
Information provided by:
Providence Health & Services
ClinicalTrials.gov Identifier:
NCT00892879
First received: April 27, 2009
Last updated: May 17, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a single-institution, prospective, one-to-one randomized controlled research study. Subjects medically determined to need a cholecystectomy will be consented for surgery and study participation prior to enrolment in this study. Patients will then be randomized to receive either a single port laparoscopic cholecystectomy or a four port laparoscopic cholecystectomy.
| Condition | Intervention | Phase |
|---|---|---|
|
Cholecystectomy, Laparoscopic |
Device: Laparoscopic cholecystectomy surgery |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Randomized Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy |
Further study details as provided by Providence Health & Services:
Primary Outcome Measures:
- Post-operative pain scores (visual analogue pain scale from 0-10)assessed on post-operative day 1 and at the post-operative follow up visit in clinic. The mean pain scores will be compared using student's t-test. [ Time Frame: 3-6 weeks ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- The postoperative infection rate will be monitored and compared for patients undergoing single port laparoscopic cholecystectomy and four port laparoscopic cholecystectomy. [ Time Frame: 3-6 weeks ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 50 |
| Study Start Date: | February 2009 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Single port laparoscopic device
|
Device: Laparoscopic cholecystectomy surgery
Single port laparoscopic cholecystectomy surgery versus a standard four port device.
Other Name: ACS Triport, Advanced Surgical Concepts, Ireland
|
|
Active Comparator: 2
Four-port laparoscopic device
|
Device: Laparoscopic cholecystectomy surgery
Single port laparoscopic cholecystectomy surgery versus a standard four port device.
Other Name: ACS Triport, Advanced Surgical Concepts, Ireland
|
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
Pre-operative diagnosis of one of the following:
- Pancreatic cholecystitis
- Biliary cholic
- Biliary dyskinesia
- Choledocholithiasis status post endoscopic retrograde cholangiopancreatography/sphincterotomy
- Gallbladder polyps
- Other diagnosis at the discretion of the surgeon
Exclusion Criteria:
- Acute cholecystitis
- Gallstones > 2.5cm in length on ultrasound
- Suspected presence of common duct stones
- History of jaundice
- History of gallstone pancreatic
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00892879
Locations
| United States, Oregon | |
| Providence Portland Medical Center | |
| Portland, Oregon, United States, 97213 | |
Sponsors and Collaborators
Providence Health & Services
Investigators
| Principal Investigator: | Paul D Hansen, MD | Providence Health & Services |
More Information
No publications provided by Providence Health & Services
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Paul Hansen, MD, Providence Health & Services |
| ClinicalTrials.gov Identifier: | NCT00892879 History of Changes |
| Other Study ID Numbers: | PHS IRB # 09-14A |
| Study First Received: | April 27, 2009 |
| Last Updated: | May 17, 2011 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 22, 2013